NKE vs UNH: Which Is the Better Buy?
Side-by-side comparison of NIKE, Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
NIKE, Inc. · Consumer Cyclical
$42.62
+38.4% upside to fair value
Med Conviction
Grade B+
VS
UnitedHealth Group Incorporated · Healthcare
$353.52
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+45.0%).
UNH trades at a lower forward P/E
(26.7x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
NKE |
UNH |
| Current Price |
$42.62 |
$353.52 |
| Fair Value Estimate |
$58.98 |
$512.60 |
| Upside to Fair Value |
+38.4%
|
+45.0%
|
| Market Cap |
$63.0B |
$320.9B |
| Forward P/E |
27.9x
|
26.7x
|
| EV / EBITDA |
20.7x
|
16.1x
|
| Price / Sales |
1.4x
|
0.7x
|
| Price / FCF |
19.4x
|
16.3x
|
| Revenue Growth YoY |
-9.8%
|
+2.0%
|
| Gross Margin |
42.7%
|
18.8%
|
| Operating Margin |
8.0%
|
4.2%
|
| Return on Equity |
24.4%
|
12.4%
|
| Dividend Yield |
3.8% |
0% |
| FCF Yield |
5.2%
|
6.13%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Nike is the world's largest athletic footwear and apparel company with $46.3B in FY2025 revenue, operating across 190+ countries with the Nike, Jordan, and Converse brands. The stock trades near its 9-year low at $42.62 after an 11% single-day crash following a Q3 FY2026 earnings report that showed 35% net income decline and weak Q4 guidance calling for a further 2-4% revenue decline. FY2025 reve…
UnitedHealth Group Incorporated operates as a leading healthcare company with two main platforms: UnitedHealthcare, providing health benefits coverage, and Optum, offering information and technology services. The company benefits from a durable competitive moat due to its scale, integrated platforms, and broad market reach serving over 170 million consumers. Despite strong revenue growth of 12% y…
Accumulation Zones
| Metric |
NKE |
UNH |
| Zone Low |
$44.23 |
$384.45 |
| Zone High |
$50.13 |
$435.71 |
| In Buy Zone? |
Yes
|
Yes
|